NEW YORK (GenomeWeb News) - Accelrys today reported declining revenues for its fiscal third quarter, accompanied by a larger net loss and a double-digit decrease in general and administrative spending.
 
For the three months ended Dec. 31, 2007, revenue fell 5 percent to $19.6 million from $20.7 million in the comparable period of the prior year.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US National Institutes of Health and the Food and Drug Administration have proposed changing gene therapy oversight, the Associated Press reports.

Nature News reports that the Salk Institute has asked for the scope of a gender discrimination lawsuit brought against it to be narrowed.

CNBC reports that the sequencing startup Veritas aims to sequence individuals who fall at extremes.

In PLOS this week: genotyping of indigenous North African goats, program to simulate evolve and resequencing studies, and more.